These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 25960218

  • 21. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
    Cheng YW, Liao LD, Yang Q, Chen Y, Nie PJ, Zhang XJ, Xie JJ, Shan BE, Zhao LM, Xu LY, Li EM.
    Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma.
    Bai LY, Chiu CF, Pan SL, Sargeant AM, Shieh TM, Wang YC, Weng JR.
    Oral Oncol; 2011 Dec; 47(12):1127-33. PubMed ID: 21865079
    [Abstract] [Full Text] [Related]

  • 23. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells.
    Mandl-Weber S, Meinel FG, Jankowsky R, Oduncu F, Schmidmaier R, Baumann P.
    Br J Haematol; 2010 May; 149(4):518-28. PubMed ID: 20201941
    [Abstract] [Full Text] [Related]

  • 24. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY, Dai Y, Grant S.
    Clin Cancer Res; 2004 Jun 01; 10(11):3839-52. PubMed ID: 15173093
    [Abstract] [Full Text] [Related]

  • 25. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 26. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
    Park SH, Lee JH, Lee GB, Byun HJ, Kim BR, Park CY, Kim HB, Rho SB.
    Cell Signal; 2012 Mar 01; 24(3):726-33. PubMed ID: 22142513
    [Abstract] [Full Text] [Related]

  • 27. Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway.
    Ling Y, Xu C, Luo L, Cao J, Feng J, Xue Y, Zhu Q, Ju C, Li F, Zhang Y, Zhang Y, Ling X.
    J Med Chem; 2015 Dec 10; 58(23):9214-27. PubMed ID: 26555243
    [Abstract] [Full Text] [Related]

  • 28. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
    Xia Y, Lei Q, Zhu Y, Ye T, Wang N, Li G, Shi X, Liu Y, Shao B, Yin T, Zhao L, Wu W, Song X, Xiong Y, Wei Y, Yu L.
    Cancer Lett; 2014 Dec 28; 355(2):297-309. PubMed ID: 25301449
    [Abstract] [Full Text] [Related]

  • 29. L-carnosine induces apoptosis/cell cycle arrest via suppression of NF-κB/STAT1 pathway in HCT116 colorectal cancer cells.
    Lee J, Park JR, Lee H, Jang S, Ryu SM, Kim H, Kim D, Jang A, Yang SR.
    In Vitro Cell Dev Biol Anim; 2018 Aug 28; 54(7):505-512. PubMed ID: 29869056
    [Abstract] [Full Text] [Related]

  • 30. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Oh ET, Park MT, Choi BH, Ro S, Choi EK, Jeong SY, Park HJ.
    Invest New Drugs; 2012 Apr 28; 30(2):435-42. PubMed ID: 20978925
    [Abstract] [Full Text] [Related]

  • 31. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
    Ma J, Guo X, Zhang S, Liu H, Lu J, Dong Z, Liu K, Ming L.
    Mol Med Rep; 2015 Jun 28; 11(6):4525-31. PubMed ID: 25634603
    [Abstract] [Full Text] [Related]

  • 32. Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo.
    Huang HL, Lee HY, Tsai AC, Peng CY, Lai MJ, Wang JC, Pan SL, Teng CM, Liou JP.
    PLoS One; 2012 Jun 28; 7(8):e43645. PubMed ID: 22928010
    [Abstract] [Full Text] [Related]

  • 33. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.
    Int J Mol Med; 2008 Nov 28; 22(5):605-11. PubMed ID: 18949380
    [Abstract] [Full Text] [Related]

  • 34. Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells.
    Yang SH, Chien CM, Su JC, Chen YL, Chang LS, Lin SR.
    J Biochem Mol Toxicol; 2008 Nov 28; 22(6):396-404. PubMed ID: 19111001
    [Abstract] [Full Text] [Related]

  • 35. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.
    Bao L, Diao H, Dong N, Su X, Wang B, Mo Q, Yu H, Wang X, Chen C.
    Cell Biol Toxicol; 2016 Dec 28; 32(6):469-482. PubMed ID: 27423454
    [Abstract] [Full Text] [Related]

  • 36. Antitumor activity of di-n-butyl-(2,6-difluorobenzohydroxamato)tin(IV) against human gastric carcinoma SGC-7901 cells via G2/M cell cycle arrest and cell apoptosis.
    Yunlan L, Juan Z, Qingshan L.
    PLoS One; 2014 Dec 28; 9(3):e90793. PubMed ID: 24643073
    [Abstract] [Full Text] [Related]

  • 37. Deoxyelephantopin impairs growth of cervical carcinoma SiHa cells and induces apoptosis by targeting multiple molecular signaling pathways.
    Farha AK, Dhanya SR, Mangalam SN, Geetha BS, Latha PG, Remani P.
    Cell Biol Toxicol; 2014 Dec 28; 30(6):331-43. PubMed ID: 25260383
    [Abstract] [Full Text] [Related]

  • 38. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity.
    Kang KA, Piao MJ, Kim KC, Zheng J, Yao CW, Cha JW, Kim HS, Kim DH, Bae SC, Hyun JW.
    Int J Oncol; 2013 Dec 28; 43(6):1907-14. PubMed ID: 24100442
    [Abstract] [Full Text] [Related]

  • 39. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC, Huang HH, Lai CY, Lin YJ, Liou JP, Lai MJ, Li YH, Teng CM, Yang CR.
    Oncotarget; 2016 Jan 05; 7(1):402-17. PubMed ID: 26587975
    [Abstract] [Full Text] [Related]

  • 40. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
    Li HY, Ye HG, Chen CQ, Yin LH, Wu JB, He LC, Gao SM.
    J Cell Biochem; 2015 Feb 05; 116(2):287-98. PubMed ID: 25187418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.